Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cellsin vitro: Association with the Induction of Apoptosis in Leukemia HL-60 Cells-Reference-Cited by-同舟云学术

Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cellsin vitro: Association with the Induction of Apoptosis in Leukemia HL-60 Cells

Published:1994-06 Issue:6 Volume:85 Page:645-651
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Jing Yongkui,Ohizumi Hidekazu,Kawazoe Nobuko,Hashimoto Sachiko,Masuda Yutaka,Nakajo Shigeo,Yoshida Takemi,Kuroiwa Yukio,Nakaya Kazuyasu

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1994.tb02408.x/fullpdf

Reference22 articles.

1. Induction of differentiation of human and mouse myeloid leukemia cells by camptothecin;Chou;Biochem. Biophys. Res. Commun.,1990

2. Topoisomerase inhibitors have potent differentiation inducing activity for human and mouse myeloid leukemia cells;Nakaya;Jpn. J. Cancer Res.,1991

3. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells;Zhang;Biochem. Biophys. Res. Commun.,1991

4. Induction by bufalin of differentiation of human leukemia cells HL-60, U937 and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differ entiation of human leukemia cells in combination with other inducers;Zhang;Cancer Res.,1992

5. Geranylgeranylacetone used as an antiulcer agent is a potent inducer of differentiation of various human myeloid leukemia cell lines;Sakai;Biochem. Biophys. Res. Commun.,1993

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bufalin reprograms erythrocyte lifespan through p38 MAPK and Rac1 GTPase;Toxicon;2024-03

2. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy;Cancer Cell International;2024-01-04

3. Modern methods for identification and quantification of cardiac glycosides;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2023-11-21

4. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy;2023-08-07

5. The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells;Cell Biology and Toxicology;2023-06-16